BHC
Bausch Health Companies Inc.NYSEHealthcare$5.35-4.12%ClosedMarket Cap: $1.98B
As of 2026-04-06
Valuation
P/E (TTM)
12.77
PEG
0.03
P/B
-3.63
P/S
0.19
EV/EBITDA
7.39
DCF Value
$207.07
FCF Yield
49.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
68.3%
Operating Margin
20.1%
Net Margin
1.5%
ROE
-20.3%
ROA
0.6%
ROIC
3.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $2.84B | 63.0% | $730.1M | $-113.7M | $-0.31 | — |
| FY 2025 | $10.31B | 68.3% | $2.07B | $155.3M | $0.41 | — |
| Q3 2025 | $2.68B | 72.0% | $619.0M | $179.0M | $0.48 | — |
| Q2 2025 | $2.53B | 69.8% | $444.0M | $148.0M | $0.40 | — |
| Q1 2025 | $2.26B | 69.0% | $276.0M | $-58.0M | $-0.16 | — |
| Q4 2024 | $2.56B | 71.6% | $558.0M | $93.0M | $0.25 | — |
| FY 2024 | $9.63B | 71.1% | $1.55B | $-46.0M | $-0.13 | — |
| Q3 2024 | $2.51B | 72.3% | $318.0M | $-85.0M | $-0.23 | — |
| Q2 2024 | $2.40B | 70.1% | $389.0M | $10.0M | $0.03 | — |
| Q1 2024 | $2.15B | 70.3% | $281.0M | $-63.7M | $-0.17 | — |
| Q4 2023 | $2.41B | 70.7% | $362.0M | $-39.0M | $-0.11 | — |
| FY 2023 | $8.76B | 70.8% | $963.0M | $-592.0M | $-1.62 | — |